Last reviewed · How we verify
Glugaon RTU Injection Without Insulin Pump Reduction
At a glance
| Generic name | Glugaon RTU Injection Without Insulin Pump Reduction |
|---|---|
| Also known as | XP-3994 |
| Sponsor | Xeris Pharmaceuticals |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Injection site pain
- Injection site discomfort
- Dizziness
- Nausea
- Injection site irritation
- Upper respiratory tract infection
- Vomiting
- Injection site reaction
- Injection site paresthesia
- Application site erythema
- Application site rash
- Injection site haematoma
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |